ClinicalTrials.gg
Sign In

Nasopharyngeal Neoplasms clinical trials

The registry lists 226 studies for Nasopharyngeal Neoplasms across more than 10 countries. 42 are recruiting or about to start. 99 of them are mainly about Nasopharyngeal Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its narrower condition Nasopharyngeal Carcinoma too: 861 studies, 301 open.

Get an email when these change. Save the Nasopharyngeal Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
98
Status unknown
48
Recruiting
32
Terminated
18
Active, not recruiting
16
Not yet recruiting
9

Phase

Phase 2
103
Phase 1
47
Phase 3
23
Phase 4
5
Early Phase 1
1

Where

China
83
United States
82
Singapore
16
Canada
16
Hong Kong
10
France
9

Who runs them

Sun Yat-sen University (38) · National Cancer Institute (NCI) (12) · M.D. Anderson Cancer Center (7) · National University Hospital, Singapore (6) · Memorial Sloan Kettering Cancer Center (5) · Chinese University of Hong Kong (4) · Dana-Farber Cancer Institute (4) · Zhejiang Cancer Hospital (4)

What is being tested here

Drugs under test in Nasopharyngeal Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cisplatin2218
Gemcitabine229
Toripalimab204
Camrelizumab223
Nivolumab203
Fluorouracil106
Pembrolizumab114
Endostar protein103
Tislelizumab122
Cemiplimab101

Drug classes tested here Immune checkpoint inhibitors 12 open · Antimetabolites 3 open · Angiogenesis inhibitors 1 open · Tyrosine kinase inhibitors (TKIs) 1 open · Antimitotic agents 16

Coming up

8phase 3 studies under way
11studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 32 Nasopharyngeal Neoplasms studies recruiting now, 9 (28%) set no upper age limit and 18 (56%) stop at 75 or younger. 3 (9%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (6%) take healthy volunteers.

Recruiting studies that take each age, of 32
AgeWomenMen
102 (6%)2 (6%)
1828 (88%)28 (88%)
3032 (100%)32 (100%)
4032 (100%)32 (100%)
5032 (100%)32 (100%)
6532 (100%)32 (100%)
7522 (69%)22 (69%)
8514 (44%)14 (44%)

Across all 226 studies, recruiting or not: 39% stop at 75 or younger and 15% at 65; 13% take children; <1% are for women only and 0% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Nasopharyngeal Neoplasms studies take

Of 33 phase 2 interventional studies under Nasopharyngeal Neoplasms, half reached primary completion within 55 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 255 mo31–124 · 33 studies——
Interventional, no phase93 mo31–143 · 18 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 15, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 226. Browse all 226 → or search them.